Covered recipient · General Payments record
CHRISTINE URBANSKI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$4,567.53
- Reported across 220 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,416.43 | 62 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $240.04 | 4 |
| Incyte Corporation | $175.10 | 6 |
| Daiichi Sankyo Inc. | $154.81 | 6 |
| Janssen Biotech, Inc. | $112.23 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $99.27 | 5 |
| EISAI INC. | $67.58 | 3 |
| E.R. Squibb & Sons, L.L.C. | $54.13 | 3 |
| Celgene Corporation | $45.51 | 3 |
| ABBVIE INC. | $45.07 | 2 |
| PFIZER INC. | $42.59 | 2 |
| TerSera Therapeutics LLC | $39.38 | 2 |
| ADC Therapeutics America, Inc. | $35.43 | 2 |
| Lilly USA, LLC | $34.45 | 2 |
| Dendreon Pharmaceuticals LLC | $34.43 | 1 |
| Medtronic, Inc. | $33.19 | 1 |
| Merck Sharp & Dohme Corporation | $32.02 | 2 |
| Tempus AI, Inc | $31.51 | 2 |
| Regeneron Healthcare Solutions, Inc. | $29.05 | 1 |
| Myriad Genetic Laboratories, Inc. | $26.42 | 1 |
| Sumitomo Pharma America, Inc. | $25.76 | 1 |
| Janssen Pharmaceuticals, Inc | $23.21 | 2 |
| Deciphera Pharmaceuticals Inc. | $21.89 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $21.74 | 1 |
| GENZYME CORPORATION | $21.41 | 1 |
| BeiGene USA, Inc. | $18.92 | 1 |
| PharmaEssentia USA Corporation | $18.30 | 1 |
| ARRAY BIOPHARMA INC | $17.22 | 1 |
| Karyopharm Therapeutics Inc. | $14.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (63)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.